Reduction of acute renal allograft rejection by daclizumab. Daclizumab Double Therapy Study Group.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/F99656D1.svg?ark=w1%2F20260522%2FF99656D1)](https://nobleid.org/work/w1/20260522/F99656D1)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors